盘点:2018年4月第3期BMJ研究精选

2018-04-25 zhangfan MedSci原创

BMJ

2018年4月第3期BMJ研究精选



【1】封面文章--育龄女性需警惕丙戊酸钠治疗风险


据估计,全世界每天有一百万人服用丙戊酸钠,丙戊酸是一种γ-氨基丁酸(GABA)激动剂,用于癫痫、双相情感障碍、偏头痛以及锂盐无法控制的躁狂症的治疗。在美国,2012年约有150万名门诊病人接受丙戊酸钠治疗,其中约22%的患者(341000例)为13-45岁的育龄女性,其中67%的患者用于治疗情绪和精神障碍,9%用于偏头痛,9%用于癫痫。

国际共识认定丙戊酸是一种严重的致畸剂,但对于育龄女性是否可以服用丙戊酸钠尚未达成一致。部分学者主张禁止在怀孕期间以及育龄女性中使用丙戊酸钠,而另一些人则支持在某些情况下,包括在怀孕期间,限制性的服用丙戊酸钠。

2018年3月,欧洲和英国药物监管部门就生育年龄妇女使用丙戊酸盐的管理发表了最新声明:

1、对于偏头痛或双相障碍人群,妊娠期女性禁止服用丙戊酸钠;对于育龄期女性,除非患者无生育能力或计划,不应接受丙戊酸钠治疗。

2、对于癫痫人群,妊娠期女性应禁止服用丙戊酸钠,但对于无法停止丙戊酸钠治疗的妊娠女性,在适当的护理条件下可坚持丙戊酸钠治疗;对于育龄期女性,除非患者无生育能力或计划,不应接受丙戊酸钠治疗。

【2】氟哌啶醇治疗增加急性心肌梗死死亡风险


近日研究人员对非典型抗精神病药物导致的急性心肌梗死死亡事件进行了考察。6578名18岁以上因口服氟哌啶醇或非典型抗精神病药物(喹硫平,奥氮平和利培酮)导致的急性心肌梗死住院患者参与,研究的主要终点是7天内院内死亡。

患者平均年龄75.2岁,其中1668名患者服用了氟哌啶醇(25.4%),4910 人(74.6%)服用了其他抗精神病药。氟哌啶醇组每100患者天死亡1.7例(总计死亡患者数129例),其他药物组为1.1例(92例)。7天内,氟哌啶醇组患者生存率为0.93,其他药物组为0.94。未调整和调整后的死亡风险分别为1.51和1.50,死亡相关风险在住院前4天最高,之后逐渐降低。

【3】I型糖尿病患者接受人工胰腺治疗对血糖的控制效果优于胰岛素疗法


近日研究人员就非妊娠门诊I型糖尿病患者接受人工胰腺治疗的疗效和安全性进行了评估。

涉及非妊娠门诊I型糖尿病患者接受任何类型的人工胰腺治疗与任何类型的胰岛素治疗的比较研究纳入本次荟萃分析。研究的主要终点为血糖范围3.9-10 mmol/L患者比例,次终点包括血糖低于3.9 mmol/L或高于10 mmol/L的患者比例、低血糖指数、平均血糖水平、每日胰岛素总需要量和糖化血红蛋白水平。

40个临床研究,总计1027名参与者。研究发现,接受人工胰腺治疗患者血糖范围达标患者比例显著高于接受胰岛素治疗的人群,其夜间血糖以及24小时血糖指标差异分别为15.15%和9.62%。接受人工胰腺治疗患者,夜间及24小时血糖超出正常范围的比例显著降低(8.52%和1.19%)。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1848502, encodeId=3e121848502c6, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed May 09 05:04:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309864, encodeId=3a303098641e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ6VKTBLeEm0k8CfowXtdj2bKPdYZZ1ic3I2RicDp2PHfdDfKX6ibD4F08Le1WD0h6wIcNB9ica3HGJ5g/132, createdBy=738f1693639, createdName=1de6402cm45(暂无匿称), createdTime=Fri Apr 27 20:12:12 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309617, encodeId=703130961e5c, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Apr 27 02:30:24 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309483, encodeId=3226309483a3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Thu Apr 26 14:01:11 CST 2018, time=2018-04-26, status=1, ipAttribution=)]
    2018-05-09 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1848502, encodeId=3e121848502c6, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed May 09 05:04:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309864, encodeId=3a303098641e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ6VKTBLeEm0k8CfowXtdj2bKPdYZZ1ic3I2RicDp2PHfdDfKX6ibD4F08Le1WD0h6wIcNB9ica3HGJ5g/132, createdBy=738f1693639, createdName=1de6402cm45(暂无匿称), createdTime=Fri Apr 27 20:12:12 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309617, encodeId=703130961e5c, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Apr 27 02:30:24 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309483, encodeId=3226309483a3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Thu Apr 26 14:01:11 CST 2018, time=2018-04-26, status=1, ipAttribution=)]
    2018-04-27 1de6402cm45(暂无匿称)

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1848502, encodeId=3e121848502c6, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed May 09 05:04:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309864, encodeId=3a303098641e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ6VKTBLeEm0k8CfowXtdj2bKPdYZZ1ic3I2RicDp2PHfdDfKX6ibD4F08Le1WD0h6wIcNB9ica3HGJ5g/132, createdBy=738f1693639, createdName=1de6402cm45(暂无匿称), createdTime=Fri Apr 27 20:12:12 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309617, encodeId=703130961e5c, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Apr 27 02:30:24 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309483, encodeId=3226309483a3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Thu Apr 26 14:01:11 CST 2018, time=2018-04-26, status=1, ipAttribution=)]
    2018-04-27 1209e435m98(暂无昵称)

    学习了.谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1848502, encodeId=3e121848502c6, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed May 09 05:04:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309864, encodeId=3a303098641e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ6VKTBLeEm0k8CfowXtdj2bKPdYZZ1ic3I2RicDp2PHfdDfKX6ibD4F08Le1WD0h6wIcNB9ica3HGJ5g/132, createdBy=738f1693639, createdName=1de6402cm45(暂无匿称), createdTime=Fri Apr 27 20:12:12 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309617, encodeId=703130961e5c, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Fri Apr 27 02:30:24 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309483, encodeId=3226309483a3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Thu Apr 26 14:01:11 CST 2018, time=2018-04-26, status=1, ipAttribution=)]
    2018-04-26 yfjms

    学习

    0

相关资讯

盘点:2018年3月第1期BMJ研究精选

2018年3月第一期BMJ研究精选

盘点:2018年3月第2期BMJ研究精选

2018年3月第2期研究精选

盘点:2018年4月第1期BMJ研究精选

2018年4月第1期BMJ研究精选

盘点:2018年3月第3期BMJ研究精选

2018年3月第3期BMJ研究精选

盘点:2018年4月第2期BMJ研究精选

2018年4月第2期BMJ研究精选

盘点:2018年3月第4期BMJ研究精选

2018年3月第4期BMJ研究精选